最新医学　別冊　新しい診断と治療のABC　9　躁うつ病

出版社： 最新医学社
発行日： 2003-01-25
分野： 臨床医学：一般  >  雑誌
雑誌名：
特集： 躁うつ病
電子書籍版： 2003-01-25
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

5,500 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

4,400 円(税込)

購入する

商品紹介

シリーズ第9巻として、「躁うつ病」を取り上げました。「躁うつ病」で受診する患者数が明らかに増加しています。病因論は未だ定説がないとは言え、ここ数年、有効性が高く、副作用が少ない抗うつ薬が治療に寄与し、効果を上げるようになってきました。本書は「躁うつ病」の概念から診断・治療法、治療薬などについて、臨床の場ですぐに役立つ最新情報をお届けします。各領域の経験豊富な専門家により執筆された本書は第一線の臨床家には必読の実用書です。

目次

  • 最新医学　別冊　新しい診断と治療のABC ９　躁うつ病

    ―　目次　―

    第１章　躁うつ病の概念・定義
    概念・定義 国立病院東京医療センター 島内智子ほか
    疫学 熊本大学 森健太ほか

    第２章　躁うつ病の病理・病態生理
    遺伝 帝京大学 赤羽晃寿ほか
    薬理神経化学仮説 北海道大学 井上猛ほか
    神経内分泌仮説 昭和大学 大嶋明彦
    ほか

    第３章　躁うつ病の診断
    うつ病の診断 防衛医科大学 野村総一郎
    躁病の診断 山梨大学 井上由美子ほか
    鑑別診断 東京女子医大 福永貴子

    第４章　躁うつ病の管理・治療
    うつ病の管理・治療 慈恵医大 忽滑谷和孝
    躁病の管理・治療 国立南花巻病院 澁谷治男
    治療薬剤：
    　(1)抗うつ薬 河田病院 渡邉昌祐
    　(2)気分安定薬 昭和大学 中込和幸
    　(3)抗精神病薬・抗不安薬・睡眠薬 徳島大学 大森哲郎
    ほか

    第５章　躁うつ病のガイドライン
    躁うつ病の治療ガイドライン 国立精神・神経センター 樋口輝彦

    座談会　今日の躁うつ病臨床
    東京慈恵医大 牛島定信 　　 理化学研究所 加藤忠史
    （司会） 昭和大学 上島国利

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 躁うつ病の概念・定義

P.16 掲載の参考文献
1) 森平淳子, 他:双極性障害の I型. II型, III型. 臨精医24 (10):1279-1285, 1995.
 
2) Akiskal H S:Soft bipolarity-A footnote to Kraepelin 100 years later-. 臨精病理21:213-211, 2000.
 
3) 広瀬徹也:気分障害をめぐる諸問題, 臨精医29 (8):817-821, 2000.
 
4) Akiskal H S:Switching from 'unipolar' to bipolar II. An 11-years prospecrtive study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 52:114-123, 1995.
 
5) Angst J:Bipolar manic-depressive psychosis:results of a geneti investigation. Hum Genet 55:237-254, 1980.
 
6) Dunner D L:Heritable factors in the severity of affective illness. Biol Psychiatry 11:31-42, 1976.
PubMed
7) 広瀬徹也:歴史・概念・分類:臨床精神医学講座4 気分障害, p 3-20, 中山書店, 東京, 1998.
 
8) Allen Frances, et al:精神分裂病と双極性障害の治療. エキスパート・コンセンサスガイドライン. ライフサイエンス, 東京, 1997.
 
P.23 掲載の参考文献
1) 高橋三郎, 他:DSMIV-TR精神疾患の診断・統計マニュアル. 医学書院, 東京, 2002.
 
2) The World Health Report 2001 Mental Health:New Understanding, New Hope, p 29-30. WHO, Geneva, 2001.
 
3) 北村俊則, 他:甲府市の一地域における精神科疫学調査-JCM診断による軽度精神障害の頻度. 日本医事新報3618:47-50, 1993.
 
4) 木村武実, 他:わが国におけるうつ病の疫学動向. 日臨59 (8):1444-1449, 2001.
 
5) 前田雅也, 他:臨床精神医学講座4気分障害, p 350-352. 中山書店, 東京, 1998.
 
6) Kitamura T, et al:Epidemiology of psychiatric disorders in Japan. In:Images in Psychiatry, p 37-46. World Psychiatric Association, Paris, 1999,
 
7) Jorm A F:Sex and age differences in depression:aquantitative synthesis of published research Aust N Z J Psychiatry 21 (1):46-53, 1987.
 
8) Kendler K S, et al:Apopulation-based twin study of life time major depression in men and women. Arch Gen Psychiatry 57:94-95, 1999.
 
9) Endicott J:The menstrual cycle and mood disorders. J Affect Disord 29:193-200, 1993.
PubMed
10) Cox J, et al:A controlled study of the onset duration and prevalence of postnatal depression. Br J Psychiatry 163:27-31, 1993.
 
11) Halbreich U:The multiple interactional biological process that might lead to depression and gender differences in its appearance. J Affect Disord 29 (2-3):159-173, 1993.
 
12) Wurtman J J:Depression and Weight gain:the serotonin connection. J Affect Disord 29 (2-3):183-192, 1993,
 
13) McEwen B S:Steroid hormones effect onbrain development and function. Horm Res 37:1-10, 1992.
 
14) Paykel E S:Life events Life events, social support and depression. Acta Psychiatr Scand Suppl 377:50-58, 1994.
PubMed
15) Wilhelm K, et al Sex difference in Uretime depression risk factors and coping strategies in a socially homogeneous group. Acta Psychiatr Scand 88 (3):205-211, 1993.
 
16) Nolen-Hoeksema S:Sex differences in unippolar depression:evidence and theory. Psychol Bull 101:259-282, 1987.
PubMed
17) Otto M W, et al:Right hemisphere involve ment in depression:toward a neuropsychological theory of negative affective experiences. Biol Psychiatry 22 (10):1201-1215, 1987.
 
18) Spitzer R L, et al:Research diagnostic criteria:rationale and reliability. Arch Gen Psychiatry 35 (6):773-782, 1978.
PubMed
19) Angst J, et al:Do the diagnostic criteria determine the sex ratio in depression? J Affect Disord 7 (3-4):189-198, 1984.
 
20) Nolen-Hoeksema S:The emergence of gender difference in depression during adolescence. Psychological Bullein 115 (3):424-443, 1994.
 
21) Ernst C, et al:Sex dfferences in depression. Evidence from longitudinal epidemiological data. Eur Arch Psychiatry Clin Neurosci
 

第2章 躁うつ病の病理・病態生理

P.30 掲載の参考文献
1) Margolis R L, et al:Trinucleotide repeat expansion and neuropsychiatric disease. Arch Gen Psychiatry 56 (11):1019-1031, 1999.
PubMed
2) Mclnnis M G, et al:Anticipation in bipolar affective disorder. Am J Hum Genet 53 (2):385-390, 1993.
 
3) Gelernter J:Genetics of bipolar affective disorder:time for another reinvention? Am J Hum Genet 56(6):1262-1266, 1995.
PubMed
4) Vincent J B, et al:Analysis of genome-wide CAG/CTG repeats, and at SEF2-IB and ERDAl in schizophrenia and bipolar affec-tive disorder. Mol Psychiatry 4 (3):229-234, 1999.
 
5) Deal C L:Parental genomic imprinting. Curr Opin Pediatr 7 (4):445-458, 1995.
PubMed
6) Nicholls R D:New insights reveal complex mechanisms involved in genomic imprinting. Am J Hum Genet 54 (5):733-740, 1994.
PubMed
7) McMahon F J, et al:Patterns of maternal transmission in bipolar affective disorder. Am J Hum Genet 56 (6):1277-1286, 1995.
PubMed
8) Craddock N, et al:Molecular genetics of bipolar disorder. Br J psychiatry 178 (Suppl 41):S 128-133, 2001.
 
9) Corder E H, et al:Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer:s disease in late onset families. Science 261 (5123):921-923, 1993.
PubMed
10) Kunugi H, et al:Manic-depressive illness and tyrosine hydroxylase gene. Lancet 348 (9023):336, 1996.
PubMed
11) Kunugi H, et al:Serotonin transporter gene polymorphisms:ethnic difference and possible association with bipolar affective disorder. Mol Psychiatry 2 (6):457-462, 1997.
PubMed
12) Kunugi H, et al:No evidence for an association of affective disorders with high-or low-activity allele of catechol-o-methyltransferase gene. Biol Psychiatry 42 (4):282-285, 1997.
 
13) Sasaki T, et al:The monoamine oxidase-A gene and major psychosis in Japanese subjects. Biol Psychiatry 44 (9):922-924, 1998.
PubMed
14) Kunugi H, et al:No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients. Am J Psychiatry 156 (5):774-776, 1999.
PubMed
15) Yoon I S, et al:Altered IMPA2 gene expression and calcium homeostasis in bipolar disorder. Mol Psychiatry 6 (6):678-683, 2001.
PubMed
16) Hara K, et al:Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japa nese population. Diabetes 51 (2):536-540, 2002.
 
17) Bezchlibnyk Y B, et al:Gene expression differences in bipolar disorder revealed by cDNA array analysis of post-mortem frontal cortex. J Neurochem 79 (4):826-834, 2001.
PubMed
P.37 掲載の参考文献
1) 井上 猛, 他:セロトニン. 感情障害-基礎と臨床-(笠原 嘉, 他 編). p 259-265, 朝倉書店, 東京, 1997.
 
2) 井上 猛, 他:抗うつ薬の歴史と分類. 臨床精神医学講座, 第14巻 (精神科薬物療法), (村崎光邦, 他 編). p 109. 中山書店, 東京, 1999.
 
3) 井上 猛, 他:ドーパミンアゴニストの難治性うつ病に対する有効性. 臨精薬理5:545-550, 2002.
 
4) 井上 猛, 他:難治性うつ病の治療戦略とその前シナプス性作用機序. 日神精薬理誌 (印刷中) .
 
5) Janicak P G, et al:Principles and Practice of Psychopharmacotherapy, 3rd edition. Lippincott Williams & Wilkins, Philadelphia, 2001.
 
6) 加賀谷有行, 他:精神疾患における細胞内カルシウム情報伝達系-神経系のモデルとしての血小板の有用性-. 神経精神薬理19:847-853, 1997.
 
7) Kusumi L et al:Serotonin-induced platelet intracellular calcium mobilization in depressed patients. Psychopharmacology 113:322-327, 1994.
 
8) Kusumi I, et al:Treatment response in deppressed patients with enhanced calcium mobilization stimulated by serotonin. Neuropsychopharmacol 23:690-696, 2000.
 
9) 前田雅也, 他:疫学. 臨床精神医学講座, 第4巻 (気分障害). (広瀬徹也, 他 編). p 21-41, 中山書店, 東京, 1998
 
10) Stoll A L, et al:Antidepressant-associated mania a controlled comparison With spontaneous mania Am J Psychiatry 151:1642-1645, 1994.
 
11) Suzuki K, et al:Serotonin-induced platelet intracellular calcium mobilization in various psychiatric disorders:is it specific to bipolar disorder? J Affect Disord 64:291-296, 2001.
PubMed
12) 高橋 良:神経化学. 現代精神医学大系:躁うつ病 (高橋 良,他 編). p 101-122. 中山書店, 東京 1979.
 
13) Williams RSB, et al:A common mechanism of action for three mood-stabilizing drugs. Nature 417:292-295, 2002.
 
P.44 掲載の参考文献
1) Garlow S J, et al:The neurochemistry of mood disorders:clinical studies. Neurobiology of mental illness (Charney D S, et al, eds). p 348-364, 0xford University Press, New York, 1999.
 
2) Holsboer F:The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiat Res 33:181-214, 1999.
PubMed
3) Kendler K S, et al:Toward a comprehensive developmental model for major depression in women. Am J Psychiatry 159 (7):1133-1145, 2002.
 
4) Steckler T, et al:Corticotropin-releasing hormone receptor subtypes and emotion. Biol Psychiatry 46:1480-1508, 1999.
PubMed
5) Dautzenberg F M, et al:The CRF peptide family and their receptors:yet more part-ners discovered. TIPS 23:71-77, 2002.
 
6) Zobel A W, et al:Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression:the first 20 patients treated. J Psychiat Res 34:171-181, 2000.
PubMed
7) Kuroda Y, et al:Effect of ACTH, adrenalectomy and the combination treatment on the density of 5-HT2 receptor binding sites in neocortex of rat forebrain and 5-HT2 receptor-mediated wet-dog shake behaviors. Psychopharmacology (Berl) 108:127-132, 1992.
 
8) Penalva R G et al Conicotropin-releasing hormone receptor type 1-deficiency enhances hippocampal serotonergic neurotransmission:an in Vivo microdialysis study in mutant mice. Neuroscience 109:253-266, 2002.
 
9) Drevets W C, et al:Glucose metabolism in the amygdala in depression:relationship to diagnostic subtype and plasma cortisol lev-els. Pharmacol Biochem Behav 71:431-447, 2002.
 
10) Shehne Y I, et al:Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 93:5034-5043, 1999.
 
11) Axelson D A, et al:Hypercortisolemia and hippocampal changes in depression. Psychiatry Res 47:163-173, 1993.
PubMed
12) Van Londen L, et al:Neuropsychological performance and plasma cortisol, arginine vasopression and oxytocin in patients With major depression. Psychol Med 28:275-284, 1998.
 
P.51 掲載の参考文献
1) Borbely A A:Atwo process model of sleep regulation. Human Neurobiol 1:195-204, 1982.
 
2) Borbely A A:The two process model of sleep regulation:implications for sleep in depression. In:Biological Rhythms & Mental Disorders (Kupfer D J, et al, eds). p 55-81. Guilford Press, New York, 1988.
 
3) Halberg F:Physiologic considerations uderlying rhythmometry, with special reference to emotional illness. ln:Cycles Biologiques et Psychiatrie (de Ajuriguerra J, ed). P 73-126. Masson & C Paris, 1968
 
4) 永山治男:時間生物学. 感情障害. 基礎と臨床(笠原嘉, 他編). p 294-299. 朝倉書店, 東京, 1997.
 
5) 永山治男:サーカディアンリズムを変える薬-時間生物薬. Clin Neurosci 18:1176-1178, 2000.
 
6) Schulz H, et al:On the origin of early REM episodes in the sleep of depressed patients a comparison of three hypothes. Psychiatr Res 16:65-77, 1985.
 
7) Wehr T A, et al:Phase advance of the circadian sleep-wake cycle as an antidepressant. Science 206:710-713, 1979.
PubMed
8) Wehr T A, et al:Biological rhythms and psychiatry. In:American Handbook of Psychiatry, Vol. vii (Arietie S, et al, eds). p 46-74. Basic Books, New York, 1981.
 
9) Wehr T A, et al:Circadian rhythm mechanisms in affective illness and in antidepres sant drug action. Pharmacopsychiatry 15:31-39, 1982.
 
P.60 掲載の参考文献
1) Jacoby R J, et al:Computed tomography in the elderly:3. Affective disorder. Br J Psychiatry 136:270-275, 1980.
PubMed
2) Rangel-Guerra R A, et al:Nuclear magnetic resonance in bipolar affective disorders. Am J Neuroradiol 4:229-231, 1983.
PubMed
3) Soares J C, et al:The anatomy of Mood Disorders-Review of Structural Neuroimaging Studies. Biol Psychiatry 41:86-106, 1997.
PubMed
4) Robinson R G, et al:Mood disorders in stroke patients:Importance of location of lesion. Brain 107:81-93, 1984.
PubMed
5) Drevets W C:Neuroimaging Studies of Mood Disorders. Biol Psychiatry 48:813-829, 2000
PubMed
6) Brown F W, et al:White matter hyperintensity signals in psychiatric and non psychiatric subjects. Am J psychiatry 149:620-625, 1992.
 
7) Coffey C E, et al:White matter hyperinten. sity on magnetic resonance imaging:Clinical and neuroanatomic correlates in the de, pressed elderly, J Neuropsychiatry Clin Neurosci 1:135-144, 1989.
 
8) McDonald W M, et al:Occurrence of subcortical hyperintensities in elderly subjects with mania. Psychiatry Res 40:211-220, 1991.
PubMed
9) Botteron K N, et al:MRI abnormalities in adolescent bipolar affective disorder. J Am Acad Child Adolesc Psychiatry 31:258-261, 1992.
PubMed
10) Lesser I M, et al:Late-onset depression with white matter lesions. Psychosomatics 34:364-367, 1993.
PubMed
11) Dewan M J. et al:Bipolar affective disorder:I. Comprehensive quantitative computed tomography. Acta Psychiatry Scand 77:670-676, 1988.
PubMed
12) Strakowski S M, et al:Structural brain abnormalities in first-episode mania. Biol Psychiatry 33:602-609, 1993.
PubMed
13) Woods B T, et al:Progressive ventricular enlargement in schizophrenia:Comparison to bipolar affective disorder and correlation with clinical course. Biol Psychiatry 27:341-352, 1990.
PubMed
14) Krishnan K R et al:Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations. Arch Gen Psychiatry 49:553-557, 1992.
PubMed
15) Coffey C E, et al:Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry 50:7-16, 1993.
PubMed
16) Bremner J D, et al:Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 51:273-279, 2002.
PubMed
17) Hirayasu Y, et al:Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry 156:1091-1093, 1999.
PubMed
18) Botteron K N, et al:Volumetric reduction in left subgenual prefrontal cortex in early on-set depression. Biol Psychiatry 51:342-344, 2002.
 
19) Rajkowska G, et al:Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression. Biol Psyclliatry 45:1085-1098. 1999.
PubMed
20) Sha P J, et al:Cortical gray matter reductions associated with trearment-resistant chronic unipolar depression. Br J psychiatry 172:527-532, 1998.
 
21) Starkstein S E, et al:Manicdepressive and pure manic states after brain lesions. Biol Psychiatry 29:149-158, 1991.
 
22) Dolan R J, et al:Altered magnetic resonance white-matter T values in patients with affective disorder. Br J Psychiatry 157:107-110, 1990.
 
23) Schlaepfer T E, et al:Decreased regional cor-tical gray matter volume in schizophrenia. Am J Psychiatry 151:842-848, 1994.
 
24) Cummings J L, et al:Secondary mania with focal cerebrovascular lesions. Am J psychiatry 141:1084-1087, 1984.
PubMed
25) Krishnan K R, et al:Neuroanatomical substrates of depression in the elderly. Eur Arc Psychiatry Clin Neurosci 243:41-46, 1993.
 
26) Dupont R M, et al:Magnetic resonance imaging and mood disorders-Localization of white matter and other subcortical abnormalities. Arch Gen Psychiatry 52:747-755, 1995.
PubMed
27) Krishnan K R, et al:Hippocampal abnormalities in depression. JNeuropsychiatry Clin Neurosci 3:387-391, 1991.
PubMed
28) Bremner J D, et al:Hippocampal volume reduction in major depression Am J psychiatry 157:115-117, 2000.
PubMed
29) Frodl T, et al:Hippocampal changes in patients with a first episode of major depression. Am J Psychiatry 159:1112-1118, 2002.
PubMed
30) Swayze V W, et al Subcortical and temporal structures in affective disorder and schizophrenia:Amagnetic resonance imaging study. Biol Psychiatry 31:221-240, 1992.
 
31) Pearlson G D, et al:Medial and superior temporal gyral volumes and cerebral asymmetry in schizophrenia versus bipolar disorder. Biol Psychiatry 41:1-14, 1997.
PubMed
32) Kemmerer M, et al:Increased hippocampalvolume in bipolar disorder [abstract]. Biol Psychiatry 35:626, 1994.
 
33) Beats B, et al:Ventricular enlargement and caudate hyperdensity in elderly depressives. Biol Psychiatry 30:452-458, 1991.
PubMed
34) Fujikawa T, et al:lncidence of silent cerebralinfarction in patients with major depression. Stroke 24:1631-1634, 1993.
 
35) Shah S A, et al:A controlled magnetic resonance imaging study. Acta Psychiatry Scand 85:474-479, 1992.
 
36) Escalona P R, et al:Reduction of cerebellar volume in major depression:A controlled MRI study. Depression 1:156-158, 1993.
 
37) Lammers G S, et al:MRI of the corpus callosum and septum pellucidum in depression. Biol Psychiatry 29:295-308, 1991.
 
38) Jurjus G J, et al:Cavum septum pellucidumin schizophrenia. affective disorder and healthycontrols:Amagnetic resonance imaging Study. Pshchol Med 23:319-322, 1993.
 
39) Bearden C E, et al The neuropsychology and neuroanatomy of bipolar affective disorder:a critical review. Bipolar Disorders 3:106-150, 2001.
PubMed
P.71 掲載の参考文献
1) 阿部輝夫, 他:単極性うつ病の神経症化-4症例の症例分析から-. 精神経誌83 (6):357-371, 1981.
 
2) American Psyatric Association:Diagnostic and Statistical Manual of Mental Disorders, 4th ed., Text Revision (DSM-IV-TR). p 652. American Psychiatric Association, Washington, D. C. 2000 (高橋三郎, 他訳:DSM-IV-TR精神疾患の診断・統計マニュアル. 医学 書院, 東京, 2002.)
 
3) Angst J:Comorbidity of mood disorders A longitudinal prospective study. Br J Psychiatry (suppl) 168:31-37, 1996.
 
4) Burger-Prinz H:Psychopathologische Bemerkungen zu den cyclischen Psychosen. Nervenarzt 21 (12):505-507, 1950.
 
5) 平沢一:うつ病にあらわれる「執着性格」の研究. 精神医4 (4):229-237, 1962.
 
6) 広瀬徹也:「逃避型抑うつ」について. 躁うつ病の精神病理2 (宮本忠雄 編). p 61-86. 弘文堂, 東京, 1977.
 
7) 広瀬徹也:精神疾患におけるcomorbidity概念の成立. 精神誌99 (11):942-949, 1997.
 
8) 飯田 真, 他:うつ病と現代-うつ病の全体像の変遷をめぐって-. 臨精医9 (1):23-33, 1980.
 
9) 飯田 真:メランコリー型の発達史論-うつ病双生児の不-致症例-. 躁うつ病の精神病理3 (飯田 真 編). p 1-19. 弘文堂東京1979
 
10) 飯田 真, 他:躁うつ病の状況論. 躁うつ病の臨床と理論 (大熊輝雄 編). p 39-65. 医学書院, 東京, 1990.
 
11) 笠原 嘉, 他:昨今の抑うつ神経症について. 精神医13 (2):139-145, 1971.
 
12) 笠原 嘉, 他:ティーンエイジャーのうつ病. 躁うつ病の精神病理2 (宮本忠雄 編). p 129-152. 弘文堂, 東京, 1977.
 
13) 笠原 嘉:退却神経症. 講談社現代新書, 東京, 1988
 
14) Kretschmer E:Korperbau und Character. Springer, Berlin, 1921, (相場 均 訳:体格と性格p 167-183, 文光堂, 東京, 1960.)
 
15) 松浪克文:うつ病の概念を考える:「神経症性うつ病」という概念の行方. 精神科治療 17 (8):969-978, 2002.
 
16) 小此木啓吾:精神分析から見たうつ病. 躁うつ病の精神病理2 (宮本忠雄 編). p 249-279. 弘文堂, 東京, 1977.
 
17) 大原健士郎:躁うつ病の社会精神医学的アプローチ. 精神誌74 (5):263-273, 1973.
 
18) Schulte W:Die Entlastungssituation als Witter-winkel fur Pathogenese und Manifestierung neurologischer und psychiatrischer Krankheiten. Nervenarzt 22 (4):140-149, 1951.
 
19) 下田光造:躁うつ病について. 米子医誌2 (1):1-2, 1950.
 
20) Tellenbach H:Melancholie. 3. Auft Springer, Heidelberg, 1976. (木村 敏 訳:メランコリー. みすず書房東京, 1978.)
 

第3章 躁うつ病の診断

P.77 掲載の参考文献
1) 野村総一郎:内科医のためのうつ病診療. 医学書院, 東京, 1998.
 
2) アメリカ精神医学会 (高橋三郎, 他 訳):DSM-IV, 精神疾患の分類と診断手引き, p 129-131. 医学書院, 東京, 1995.
 
P.86 掲載の参考文献
1) DIAGNOSTIC AND STATISTICAL MANDUAL OF MENTAL DISORDERS FOURTH EDITION TEXT REVISION, American Psychiatric Association, Washington D. C. and London, England, 2000. (高橋三郎, 他 訳:DSM-IV-TR精神疾患の診断統計マニュアル. p 335-411, 医学書院, 東京, 2002.)
 
2) Tomb D A, Psychiatry (House Officer Series). Sixth, Edition, Salt Lake City, 1999 (神庭重信監訳:レジデントのための精神医学, p 47-65. メディカル・サイエンス・インターナショナル, 東京, 2002.)
 
3) 関口英雄:躁病. 新版 精神医学事典 (加藤正明, 他 編). p 500. 弘文堂, 東京, 1993.
 
4) 西丸四方:精神医学入門. p 93-97, 南山堂, 東京, 1997.
 
5) Kaplan HI, et al:Kaplan and Sadock:s Synopsis of Psychiatry, Philadelphia 1994. (井上令一監訳:カプラン臨床精神医学テキスト, p 273-330. メディカル・サイエンス・インターナショナル, 東京, 2000.)
 
6) Gershon E S, et al:Closing in on genes for manic-depressive illness and schizophrenia Neuropsychopharmacology 18:233-242, 1998
 
P.96 掲載の参考文献
1) The American Psychiatric Association:Diagnostic and statistical manual for mental disorders 4th ed. The American Psychiatric Press, Washington DC. 1994.
PubMed
2) WHO:The ICD-10 classification of mental and behavioral disorders-Clinical description and diagnostic guidelines-. 1993.
 
3) Krauthannmer C, et al:Secondary mania. Arch Gen Psychiatry 35:1345-1348, 1978
 
4) 大熊輝雄:精神分裂病, 妄想性障害と感情障害. 現代臨床精神医学, p 315-388 金原出版, 東京, 1997.
 
5) 笠原嘉:軽症うつ病- 「ゆううつ」の精神病理p 118-136. 講談社現代新書, 東京, 1996.
 
6) 古川壽亮:気分変調症. 臨床精神医学講座4気分障害 (松下正明 編). p 257-272. 中山書店, 東京, 1998
 
7) 坂本暢典:二重うつ病. 臨床精神医学講座4気分障害 (松下正明 編). p 399-410. 中山書店, 東京, 1998
 
8) 坂元 薫:気分循環症臨床精神医学講座4気分障害 (松下正明 編). p 273-289. 中山書店, 東京, 1998.
 

第4章 躁うつ病の管理・治療

P.104 掲載の参考文献
1) Elizabeth H B, et al:The role of primary care physician in patient:s adherence to antidepressant therapy. Med Care 33:67-74, 1995.
 
2) Elizabeth H B, et al:The role of primary care physician in patient:s adherence to antidepressant therapy. Med Care 33:67-74, 1995
 
3) Alexopoulos G S, et al:Treatment of depression with heterocyclic antidepressants mono-amine oxidase inhibitors, and psychomotor stimulants. Clinicaf Geriatric Psychopharmacology (Third Edition) (Salzman C ed). p 188-208. Williams & Wilkins, Baltimore, 1998.
 
4) Rouet R H, et al:Comparative in vivo and in vitro study of the car (liac effects of milnacipran and imipramine. Fundam Clin Pharmacol 3:237-244, 1989.
 
5) Montgomery S A, et al:Efficacy and tolerability of milnacipran:an overview. Int Clin Psychopharmacol II (suppl 4):47-51, 1996.
 
6) Karasu T B:Toward a clinical model of psychotherapy for depression:2. An integrative and selective treatment approach Am J psychiatry 147:274, 1990.
 
7) Comey R H:Marital problems and treatment outcome in depressed women. Compr Psychiatry 151:652-659, 1987.
 
8) Crowtherr J H:The relationship between depression and marital maladjustment:a descriptive study. J Nerv Ment Dis 173:227-231, 1985.
 
9) Weissman M, et al:The Dpressed Women:A study of her relationships. University of Chicago Press, Chicago, 1970.
 
10) 高梨葉子, 他:難治性うつ病へのサイコエデュケーションの適応; UCLAとの共同研究から. 臨精医26 (12):15291535, 1997.
 
11) Fink M:Convulsive Therapy:Theory and Practice. Raven Press, New York, 1979. (清水信:電気けいれん療法. 星和書店, 東京, 1980)
 
12) 福迫 博, 他:磁気刺激の抗うつ作用. 脳の科学21:193-199, 1999.
 
13) Post R M et al:Repetitive transcranial magnetic stimulation as a neuropsychiatric tool:present status and future potential JECT 15:39-59, 1999.
 
14) Pascual-Leone A, et al:Lateralized effect of rapid-rate transcranial magnetic stimulation of the prefrontal cortex on moo (L Neurology 46:499-502, 1996.
 
15) Grisaru N, et al:Transcranial magnetic stim ulation in mania; a controlled study. Am J Psychiatry 155:1608-1610, 1998
 
16) Guscott R et al:The clinical meaning of re-fractory depression:a review for the clinician. Am J Psychiatry 148:695-704, 1991.
 
17) 谷向 弘:遷延うつ病の治療. 臨精医2:67-76, 1973.
 
18) 広瀬徹也:躁うつ病の慢性化, 遷延化. 精神誌81:797-802, 1979.
 
19) 井上 猛, 他:抗うつ薬に治療抵抗性のうつ病の実態とその治療戦略-自験例における調査結果と治療抵抗性うつ病の段階的治療に関する試案. 精神誌98:329-342, 1996.
 
20) 樋口輝彦, 他:難治性うつ病の実態に関する多施設共同調査研究. 脳と精の医4:135-146, 1993.
 
21) Rodin G, et al:Depression in the medically ill; An overview. Am J Psychiatry 143:696-705, 1986.
PubMed
P.114 掲載の参考文献
1) Shou M:Fouty years of lithium treatment. Arch Gen Psychiatry 54:9-19, 1997.
 
2) Goodwin F K, et al:Lithium in mania:Clinical trials and controlled studies. In Lithium:Its role in psychiatric research and therapy. (Gershon S, et al, eds). p 237-252. Plenum Press, New York, 1973.
 
3) 渡辺昌祐 編著:リチウム基礎と臨床. 医歯薬出版, 東京, 1983.
 
4) 渡辺昌祐:躁病の薬物療法精神科Mook (島薗安雄, 他 編). p 153-164. 金原出版, 東京, 1986.
 
5) 岸本 朗, 他:躁病の薬物療法 臨床精神医学講座4 気分障害 (松下正明, 他 編). p 126-140. 中山書店, 東京, 1998.
 
6) 竹崎治彦, 他:躁うつ病および症候性うつ状態に対するCarbamazepine (Tegretol) の効果. 精神医13:77-87, 1971.
 
7) Post R M, et al:Efficacy and mechanisms of action of carbamazepine in affective disorder. Biological Psychiatry (Shagass C, et al, eds) p 886-888. Elsevier Science Publishing, Amsterdam, 1985.
 
8) Okuma T, et ak Comparison of antimanic efficacy of carbamazepine and chlorpromazine by double-blind controlled study. Clin Eval 7:509-532, 1979.
 
9) Swann A C, et al:Depression during mania, treatment response to lithium or diproex. Arch Gen Psychiatry 54:37-42, 1997.
 
10) Frances A, et al:Treatment of bipolar disorder. J Clin Psychiatry 57 (suppl 12A):3-80, 1995.
 
11) 原田俊樹, 他:二重盲検法によるZotepineと炭酸リチウムの躁病に対する比較試験. 臨精医学23:1249-1262, 1994.
 
12) McElroy S L, et al:Pharmacologic agents for:the treatment of acute bipolar mania. Biol Psychiatry 48:539-557, 2000.
PubMed
13) 岸本朗:Mood stabilizerの再発予防効果. 臨精薬理 1:397-404, 1998.
 
14) Mander A J, et ah Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet ii:15-17, 1988.
 
P.124 掲載の参考文献
1) 田中克俊, 他:臨床実践の視点から:薬の選択と初期評価. 精神科治療17 (8):1005-1011, 2002.
 
2) 野村総一郎:気分障害の薬物療法. 精神誌 103 (12):1041-1045, 2001.
 
3) 塩江邦彦, 他:大うつ病の治療アルゴリズム:精神分裂病と気分障害の治療手順 (精神科薬物療法研究会編) . p 63-74, 星和書店, 東京, 1998
 
4) Stassen H H, et al:Time course of improve-ment under antidepressant treatment:asurvival-analytical approach. Eur Neuro-psychopharmacol 3 (2):127-135, 1993.
 
5) 渡邉昌祐:抗うつ薬の選び方と用い方 (改訂版) . p 114-115, 新興医学出版, 東京, 1997.
 
6) Shelton R C:Treatment options for refractory depression. J Clin Psychiatry 60 (suppl 4):57-61, 1999.
 
7) Fava M:Lithium and tricyclic augumentation of fluoxetine. treatments for resistant major depression:adouble-blind, controlled study. Am J Psychiatry 151:1372-1374, 1994. .
 
8) Kapfer D J:Long-term treatment of depression. J Clin Psychiatry 52 (suppl 5):22-34, 1991.
 
9) Prien F E, et al:Continuation drug therapy for major depressive episodes:how long should be maintained? Am J psychiatry 143:18-23, 1986.
 
10) 渡邉昌祐:SSRIのすべて. ライフサイエンス社, 東京, 2002.
 
11) 上島国利, 他編著:SNRIのすべて. 先端医学社, 東京, 2002.
 
12) Canadian Coordinating Office for Health Technology Assessment:Selective Serotonin Re-uptake Inhibitors (SSRI) for Major Depression Part 1. In (Trindale E, et al, eds). 1997.
 
13) Fava M:New approaches to the treatment of refractory depression. J Clin Psychiatry 61 (suppl 2):26--32, 2000.
 
P.130 掲載の参考文献
1) Frances A et al:Treatment of bipolar disorder J Clin Psychiatry 57 (Suppl 12A):5S-58S, 1996.
 
2) Post R M et al Beyond lithium in the treatment of bipolar illness. Neuropsychopharmacology 19:206-219, 1998.
 
3) Cade J F:Lithium salts in the treatment of psychotic excitement Med J Aust 36:349-352, 1949.
 
4) Schou M et al:The treatment of manic psychosis by the administration of lithium salts. JNeurol Neurosurg Psychiatry 17:250-260, 1954.
PubMed
5) 渡辺昌祐:躁病の薬物療法. 精神科MOOK, 躁うつ病の治療と予後 (島薗安雄, 他 編). p 153-164. 金原出版, 東京, 1986.
 
6) Calabrese J R, et al:Lithium therapy:limitations and alternatives in the treatment in bipolar disorders. Ann Clin Psychiatry 72:103-112, 1995.
 
7) Baron M, et al:Lithium carbonate responsein depression. Prediction by unipolar/bipolar illness, average-evoked response, catechol-O-methyl transferase, and family history. Arch Gen Psychiatry 32:1107-1111, 1975.
 
8) Zornberg G L, et al:Treatment of depressionin bipolar disordert new drections for research J Clin Psychopharmacol 13:397-408, 1993.
 
9) Austin M P, et al:Lithium augmentation inantidepressant-resistant patients. A quantitative analysis. Br J psychiatry 159:510-514, 1991.
PubMed
10) Maj M, et al:Long-term outcome of lithiumprophylaxis in patients initially classified as complete responders. Neuropsychopharmacology 98:535-538, 1989.
 
11) Faedda G L, et al:Outcome after rapid versus gradual disconhnuation of lithium treatment in bipolar disorders Arch Gen Psychiatry 50:448-455, 1992.
 
12) Okuma T, et al:Antimanic and prophylacticeffects of carbamazepine (Tegretol) on manicdepressive psychosis; A preliminary report, Folia Psychiat Neurol Jpn 27:283-297, 1973.
 
13) Post R M, et al:Prophylactic efficacy of carbamazepine in manic-depressive mness Am J Psychiatry 140:1602-1604, 1983.
 
14) Post R M, et al:Correlates of antimanic response to carbamazepine. Psychiatr Res 21:71-83, 1987.
 
15) Post R M, et al:Alternative approached to refractory depression in bipolar illness. Depression and Anxiety 5:175-189, 1997.
 
16) Post R M:Time course of clinical effects of carbamazepine:implications for mechanisms of action. J Clin Psychiatry 49:35-48, 1988.
PubMed
17) Post R M, et al:The place of anticonvulsant therapy in bipolar illness. Psychopharmacology 128:115-129, 1996.
PubMed
18) 樋口輝彦:バルプロ酸の双極性障害に対する臨床効果. 臨精薬理5:501-508, 2002.
 
19) Vesudev K et al:Carbamazepine and valproate monotherapy:feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic' dsorder. Psychopharmacology 150:15-23, 2000.
 
20) Puzynski S, et al:Valproic acid amide as a prophylactic agent in affective and schizoaf-fective disorders Psychopharmacol Bull 20:151-159, 1984.
 
21) Carlabrese J R, et al:Predictors of valproate response in bipolar rapid cycling. J Clin Psychiatry 13:280-283, 1993.
 
22) Denicoff K D, et al:Comparative prophylac-tic effecacy of lithium, carbamazepine, and the combination in bipolar disorder, J Clin Psychiatry 58:470-478, 1997.
 
23) Freeman M P, et ai:Mood stabilizer combinations:A review of safety and efficacy. Am J Psychiatry 155:12-21, 1998
 
24) Spina E, et al:Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet 31:198-214, 1996.
PubMed
25) Manji H K, et al:Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers:implications for the pathophysiology and treatment of manic-depressive illness. Biol Psychiatry 48:740-754, 2000.
PubMed
P.138 掲載の参考文献
1) McElroy S L, et al:Pharmacologic agents for the treatment of acute bipolar mania. Biol Psychiatry 48:539-557, 2000.
PubMed
2) Ghaemi S N:New treatments for bipolar disorder:the role of atypical neuroleptic agents. J Clin Psychiatry 61 (Suppl 14):33-42, 2000.
 
3) Freema M P, et al:Mood atabilizer combinations:areviews of safety and efficacy. Am J Psychiatry 155:12-21, 1998.
 
4) Tohen M et al Effecacy of olanzapine in combination With valproate or lithium in the treatment of mania in patients partially nonresponsive to valporate or lithium monotherapy. Arch Gen Psychiatry 59:62-69, 2002.
PubMed
5) Sachs G S, et al:Combination of a mood sta-bilizer with risperidone or haloperidol for treatment of acute mania:adouble-blind, placebocontrolled comparison of efficacy and safety. Am J Psychiatry 159:1146-1154, 2002.
 
6) Sachs GS, et al:The Expert Consensus Guideline Series:Medication Treatment of Bipolar Disorder 2000. Postgrad Med Spec No:1-104, 2000.
PubMed
7) Shelton R C, et al:A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 158:131-134, 2001.
PubMed
P.147 掲載の参考文献
1) Beck A T:Thinking and depression:I. Idiosyncratic content and cognitive distortions. Arch Gen Psychiatry 9:324-333, 1963.
PubMed
2) Beck A T:Thinking and depression:II. Theory and therapy. Arch Gen Psychiatry 10:561-571, 1964.
PubMed
3) Beck A T:Cognitive therapy and emotional disorders. International University Press, New York, 1976. (大野 裕 訳:認知療法. 岩崎学術出版社, 東京, 1990.)
 
4) Beck A T, et al Cognitive Therapy of depression. Guilford Press, New York, 1979. (坂野雄二 監訳:うつ病の認知療法. 岩崎学術出版社, 東京, 1992.) .
 
5) Burns D D:Felling good:The new mood therapy. Avon Books, New York, 1980 (野村総一郎, 他訳:いやな気分よさようなら. 星和書店, 東京, 1990.)
 
6) 大野 裕:認知療法. 精神医31:794-805, 1989.
 
7) Freeman A:認知療法入門 (遊佐安一郎監訳). 星和書店, 東京, 1989.
 
8) Hasselt V B V, et al: 1996 Sourcebook of psychological treatment manuals for adult disorders Plenum Press, New York (坂野雄二・不安・抑うつ臨床研究会 編訳:エビデンスベイスド心理治療マニュアル. 日本評論社東京, 2000.)
 
9) 井上和臣:うつ病の認知療法. 精神経誌91:647-654, 1989.
 
10) 坂野雄二:認知行動療法 日本評論社, 東京, 1995.
 
P.154 掲載の参考文献
1) Abrams R Electroconvulsive Therapy, Third Ed. Oxford University Press, New York, 1997.
 
2) American Psychiatric Association. Task Force on Electroconvulsive Therapy:The Practice of Electroconvulsive Therapy:Recommendations for Treatment, Training, and Privileging, Second Ed. American Psychiatric Association, Washington, D. C. 2001. (日本精神神経学会電気けいれん療法の手技と適応基準の検討小委員会訳:ECT実践ガイド. 医学書院,東京, 2002.)
 
3) Gagne G G Jr, et al:Ethcacy of continuation ECT and antidepressant drugs compared to long-term antidepressants alone in depressed patients. Am J Psychiatry 157:1960-1965, 2000.
 
4) Lauritzen L et al:Relapse prevention by means of paroxetine in ECT-treated patients with major depression:acomparison with imipramine and placebo in medium-term continuation therapy. Acta Psychiatr Scand 94:241-251, 1996.
 
5) 本橋伸高:ECTマニュアル-科学的精神医学をめざして. 医学書院, 東京, 2000.
 
6) 本橋伸高:気分障害の治療ガイドライン. 電気けいれん療法. 精神科治療学. 星和書店, 東京, (印刷中)
 
7) Sackeim H A, et al:Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy. A randomized controlled trial. JAMA 285:12991307, 2001.
PubMed
8) Weiner R D, et al:Effects of electroconvulsive therapy upon brain electrical activity. Ann N Y Acad Sci 462:270-281, 1986.
PubMed
P.159 掲載の参考文献
1) Barker A T, et al:Non-invasive stimualatin of the human motor cortex. Lancet 1:1106-1107, 1985.
 
2) George M S, et al:Daily repetitve transcranial magnetic stimulation (rTMS) improves mood in depression. Neuro Report 6:1853-1856, 1995.
 
3) Jing H, et al:Observation of EEG coherence after repetitive transcranial magnetic stimulation. Clin Neurophysiol 111:1282-1292, 2000.
 
4) Jing H, et al:Effects of high frequency repetitive transcmial magnetic stimulation on P 300 event-related potentials. Clin Neurophysiol 112:304, 2001.
 
5) Jing H, et al:Comparison of eventrelated potentials after repetitive transcranial magnetic stimulation. Clin Neurophysiol 248:188, 2001.
 
6) Pascual-Leone A, et al:Akinesia in Parkinson`s disease II. Shortening of choice reaction time and movement with subthreshold repetitive trans Cranial motor cortex stimulation. Neurology 44:892-898, 1994.
 
7) Takigawa M:Rhythmic light therapy for depression and data processing analysis of its effects by directed coherence. Act Nerv Super Praha 30 (3):177-180, 1988.
PubMed
8) Takigawa M, et al:EEG analysis of epilepsy by directed coherence method. A data processing approach. Int J psychophysiol 21 (2/3):65-73, 1996.
 
9) 滝川守国:高頻度反復経頭蓋磁気刺激. 臨床脳波42:333-338, 2000.
 
10) 滝川守国:高頻度経頭蓋磁気刺激法の治療応用-主として健康被験者の視点から眺める-. 臨床神経生理学28:414-424, 2000.
 
11) 滝川守国:磁気刺激療法の精神科領域における治療応用-主としてうつ病を対象として-, 臨床神経生理学30:19-28, 2002.
 
12) Wassermann E M:Risk and safety of repetitive transcranial magnetic Stimulation:report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation. June 5-7, 1996. Electroencephalogr Clin Neurophysiol 108:1-16, 1998.
PubMed
P.163 掲載の参考文献
1) 朝倉哲彦, 他:迷走神経刺激によるてんかんの治療-てんかんの新しい治療法-. 医のあゆみ164:571, 1993.
 
2) George M S, et al:Vagus nerve stimulationtherapy:A research update. Neurology 24:56 (6 Suppl 3):s 56-s 61, 2002.
 
3) George M S, et al:Vagus nerve stimulation. A potential therapy for resistant depression? Psychiatr Clin North Am 23 (4):757-783, 2000.
PubMed
4) Rush A J, et al:Vagus nerve stimulation (VNS) for treatment resistant depressions:a multicenter study. Biol Psychiatry 47 (3):276-286, 2000.
 
5) Sackeim H A, et al:Vagus nerve stimulation (VNS) for treatment-resistant depression efficacy. side effects and predictors of outcome. Neuropsychopharmacology 25 (5):713-728, 2001.
PubMed
P.167 掲載の参考文献
1) Lewy A J, et al:Light suppresses melatonin secretion in humans. Science 210:1267-1269, 1980.
PubMed
2) Light A J, et al:Winter depression and the phase-shift hypothesis for bright lights therapeutic effects, history, theory and experimental evidence. J Biol Rhythms 3:121-134, 1988
 
3) Rosenthal N E, et al:Seasonal affective disorder a description of the syndrome and preliminary findings with light therapy. Arch Gen Psychiatry 41:72-80, 1984.
PubMed
4) Takigawa M:Rhythmic light therapy for depression and data processing analysis of its effects by drected coherence Activ Nerv Sup (Praha) 30:177-180, 1988
PubMed
5) Terman M, et al:Predictors of response and nonresponse to light treatment for depression Am J Psychiatry 153:1423-1429, 1996.
PubMed
6) Terman M, et al:Light therapy for seasonal affective disorders. A review of ethcacy. Neuropsychopharmacology 2:1-27, 1989.
PubMed
P.170 掲載の参考文献
1) Leibenluft E, et al:Is sleep deprivation useful in the treatment of depression? Am J Psychiatry 149:159-1681992.
PubMed
2) Tolle R:うつ病の断眠療法 (内山 真, 他 訳と解説) 精神医38:313-319, 1996.
 
3) Pflug B, et al:Disturbance of the 24-hour rhythm in endogenous depression and the treatment of endogenous depression by sleep deprivation. Int Pharmacopsychiatry 6 (3):187-196, 1971.
PubMed
4) Vogel G W, et al:REM sleep reduction effects on depression syndromes. Arch Gen Psychiatry 32 (6):765-777, 1975.
PubMed
5) Vogel G W, et al:Improrement of depression by REM sleep deprivation. New findings and a theory. Arch Gen Psychiatry 37 (3):247-253, 1980
 
6) Wehr T A, et al:Phase advance of the cir cadian sleep wake cycle as an antidepressant. Science 206:710-713, 1979.
 
7) Wu J C, et al:The biological basis of an antidepressant response to sleep deprivation and relapse:Review and hypothesis. Am J Psychiatry 147:14-21, 1990.
PubMed
P.178 掲載の参考文献
1) Robinson R G:The Clinical Neuropsychiatry of Stroke. Cambridge University Press, Cambridge, 1998. (遠藤俊吉, 他 監訳:脳卒中における臨床神経精神医学. 星和書店, 東京, 2002.)
 
2) Krishnan K R, et al:Leukoencephalopathy in patients diagnosed as major depressive Biol Psychiatry 23 (5):519-522, 1988.
PubMed
3) Coffey C E, et al:Leukoencephalopathy in elderly depressed patients refer for ECT. Biol Psychiatry 24 (2):143-161, 1988.
 
4) Fujikawa T, et al:Incidence of silent cerebral infarction in patients with major depression. Stroke 24 (11):1631-1634, 1993.
PubMed
5) American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders:DSM-IV. 4th ed. American Psychiatric Press Inc, Washington, DC, 1994.
 
6) Alexopoulos G S, et al:'Vascular depression' hypothesis. Arch Gen Psychiatry 54 (10):915-922, 1997.
PubMed
7) Steffens D C, et al:Structual neuroimaging and mood disorders:recent findings, implications for classification, and future directions. Biol Psychiatry 43 (10):705-712, 1998.
 
8) 下田健吾:脳卒中後うつ病と病変部位の関連. こころの臨ア・ラ・カルト21 (3):33-37, 2002.
 
9) Thomas A J, et al:Ischemic basis for deep white matter hyperintensities in major depression:a neuropathological study. Arch Gen Psychiatry 59 (9):785-792, 2002.
PubMed
10) Kimura M, et al:Treatment of cognitive impairment after poststroke depression:a double-blind treatment trial Stroke 31 (7) 1482-1486, 2000.
PubMed
11) Tateno A et al:The effect of post Stroke depression on recovery from stroke Psychogeriatrics 2 (2):71-84, 2002.
 
12) Taragano F E, et al:A double blind, randomized clinical trial assessing the efficacy and safety of augmenting standard antide-pressant therapy with nimodipine in thetreatment of 'vascular depression'. Int J Geriatr Psychiatry 16 (3):254-260, 2001.
 
13) 木村真人:血管性うつ病 (Vascular depression) の概念とその薬物療法. 臨精薬理 5 (11):1549-1556, 2002.
 
14) Krishnan K R et al:Clinical and treatrnent response characteristics of late-1ife depression associated with vascular disease:a pooled analysis of two multicenter trials with sertraline. Prog Neuropsychopharmacol Biol Psychiatry 25 (2):347-361, 2001.
 
15) Kimura M, et al:Therapeutic effects of milnacipran, a serotonin and noradrenaline re-uptake inhibitor, on post-stroke depression. Int Clin Psychopharmacol 17 (3):121-125, 2002.
 
16) Murray G B, et al:Electroconvulsive therapy forpoststroke depression. J Clin Psychiatry 47 (5):258-260, 1986.
PubMed
17) Lincoln N B, et al:Evaluation of cognitive behavioural treatment for depression after stroke:a pilot study. Clin Rehab 11 (2):114-122, 1997.
PubMed
P.188 掲載の参考文献
1) Dilling H, et al:Basiswissen Psychiatrie und Psychotherapie 4. Auf., P 116-122. Springer Verlag, Berlin, 2001.
 
2) Stoudemire A:Clinical Psychiatry for Medical Student. p 342-344. J. B. Lippincot Company, Philadelphia, 1994.
 
3) 濱田秀伯:退行期および老年期うつ病. 今日のうつ病治療 (上島国利 編). p 139-148. 金剛出版, 東京, 1990.
 
4) 高橋祥友:老年期うつ病. 日本評論社, 東京, 1998.
 
5) 笠原嘉:外来精神医学から, p 1-23. みすず書房, 東京, 1991.
 
6) 切替辰哉:精神医学的性格学, p 73-78. 金原出版東京, 1985.
 
7) 高橋祥友:老年期うつ病の予防. 老年精医誌12 (3):263-268, 2001.
 
8) 筒井末春:壮年期の躁うつ病. 躁うつ病の臨床と理論 (大熊輝雄 編). p 254-264. 医学書院, 東京, 1990.
 
9) 大坪天平, 他:薬剤惹起性うつ病. 精神科治療13:143-150, 1998
 
10) Maureen G et al編:老年期のうつ病 (西村 健, 他 訳) . p 194. 西村書店, 新潟, 1995.
 
11) 本間 昭, 他:老年期の感情障害. 躁うつ病の臨床と理論 (大熊輝雄 編). p 265-278. 医学書院, 東京, 1990.
 
12) 柏瀬宏隆:心の医学. 朝倉書店, 東京, 1993.
 
13) 大森健一:老年期うつ病の臨床. 老年精医 誌11 (12):1389-1392, 2000.
 
14) 三山吉夫:痴呆の前駆症状としてのうつ状態. 老年精医誌11 (12):1398-1402, 2000.
 
15) 三村将:老年期うつ病の診断と治療. Geriatr Med 40 (4):433-439, 2002.
 
16) 立山萬里:「皮膚寄生虫妄想」の臨床的研究. 慶應医58 (4):585-608, 1981.
 
17) 上島国利:国内におけるmilnacipranの基礎と臨床. 臨精薬理4 (8):1177-1189, 2001.
 
18) 白川 治:老年期うつ病の薬物療法の実際. Geriatr Med 40 (4):451-459, 2002.
Medical*Online
19) 立山萬里,他:精神疾患治療薬の使い方-うつ病. クリニカ29 (5):60-65, 2002.
 
20) 立山萬里:他の精神科治療薬法との関連. 改訂 新版2001精神科治療薬大系上巻 (三浦貞則 監修,他 編), p 590-647. 星和書店, 東京, 2001.
 
P.196 掲載の参考文献
1) Wells K B, et al:The course of depression in adult outpatients:results from the Medical Outcomes Study. Arch Gen Psychiatry 49:788-794, 1992.
PubMed
2) Chen L S, et al Empirical examination of current depression categories in a population-based study:symptoms, course, and risk factors. Am J Psychiatry 157:573-580, 2000.
 
3) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders:Clinical descriptions and diagnostic guide-lines, 1992. (融 道男, 他 監訳:ICD-10精神 および行動の障害-臨床記述と診断ガイドライン-. 医学書院, 東京, 1993.)
 
4) World Health Organization:The ICD-10 Classification of Mental and Behavioural Disorders:Diagnostic criteria for research, 1992. (中根允文, 他監訳:ICD-10精神および行動の障害-DCR研究用診断基準-. 医学書院, 東京, 1994.)
 
5) American Psychiatric Association:Quick Reference to the Diagnostic Criteria from DSM-IV-TR. American Psychiatric Association, Washington D. C., 2000. (高橋三郎, 他 監訳:DSM-IV-TR精神疾患の分類と診断の手引. 医学書院, 東京, 2002.)
 
6) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision:DSM-IV-TR. American Psychiatric Association, Washington D.C., 2000. (高橋三郎, 他 監訳:DSM-IV-TR精神疾患の診断・統計マニュアル. 医学書院, 東京, 2002.)
 
7) 久保木富房:内科医のうつ病初期療法. 日臨59:1564-1569, 2001.
 
8) 佐々木 直:軽症うつ病. 臨床医26:34-38 2000.
 
9) Maier W, et al:The risk of minor depression in families of probands with major depression:sex differences and familiarity. Eur Arch Psychiatry Clin Neurosci 242:89-92, 1992.
 
10) Wells K B, et al:The course of depression in adult outpatients:results from the Medical Outcomes Study. Arch Gen Psychiatry 49:788-794, 1992.
PubMed
11) 笠原 嘉:軽症うつ病-「ゆううつ」の精神病理. p 147-170, 講談社, 東京, 1996.
 
12) Ronalds C, et al:Outcome of anxiety and depressive disorders in primary care. Br J Psychiatry 171:427-433, 1997.
PubMed
13) Williams J W, et al:Treatment of dysthymia and minor depression in primary care. A randomized controlled trial in older adults. JAMA 284:1519-1526, 2000.
PubMed
P.204 掲載の参考文献
1) Dunner D L, et al:Clinical factors in lithium carbonate prophylaxis failure. Arch Gen Psychiatry 30:229-223, 1974.
PubMed
2) 山田和夫:ラピッド・サイクラー.「KEY WORD 精神 1998」, p 126-127. 先端医学社, 東京, 1998.
 
3) Post R M, et al:Differential effects of carbamazepine and lithium on sensitization and kinding, Prog Neuropsychopharmacol Biol Psychiatry 8:425-434, 1984.
 
4) Post R M, et al:Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry 149:191-201, 1986.
 
5) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders (4th ed.). American Psychiatric Press, Washington, DC, 1994.
PubMed
6) 山田和夫:ラピッド・サイクラー. 臨床精神医学講座4:気分障害 (広瀬徹也, 他 編). p 325-347. 中山書店, 東京, 1998.
 
7) 山田和夫:躁病躁状態. (多賀須幸夫, 他 編) 「TODAY'S THERAPY 2001. 今日の治療指針」, p 283-284. 医学書院, 東京, 2001.
 
8) 山田和夫:Rapid Cyclerに対するリチウムの効果. 平成13年度厚生省精神・神経疾患研究委託費, 感情障害の薬物治療ガイドラインの作成とその実証的研究班報告集, 47-50, 2002.
 
9) Yamada K:Algorithm for the treatment of rapid cycling. Psychiat Clin Neurosci 53 (suppl):S 73-75, 1999.
 
10) 山田和夫:SSRI/SNRI使用により再発予防効果, 躁転率に違いはあるか. 精神科1:116-122, 2002.
 
11) Dunner D L:Rapid cycling bipolar manic depressive illness. Psychiatry Clin North Am 2:461-467, 1979.
 
12) Wehr T A, et al Rapid cyclng in manic-depres-sive induced by tricyclic antidepressants. Arch Gen Psychyiatry 36:555-559, 1979.
 
13) Wehr T A, et al:Can antidepressants cause mania and worsen the course of affective illness? Am J Psychiatry 144:1403-1411, 1987.
PubMed
14) Chouinard G:Clonazepam in acute and affective disorders. J Clin Psychiatry 48 (Suppl):26-36, 1987,
 
15) Ballenger J C, et al:Therapeutic effects of carbamazepine in affective illness; a preliminary report Commun Psychopharmacol 2:159-175, 1978.
PubMed
16) Chouinard G, et al:Antimanic effect of clon azepam. Biol Psychiatry 18:451-466, 1983,
 
17) 馬場信二, 他:Rapid cycling affective disorder に対するlithium, carbamazepine, clonazepam 併用療法の効果. 精神医3:399-408, 1992.
 
18) 渡辺昌祐:感情障害における診断と治療の問題点. 第1回横浜感情障害研究会抄録1997.
 
19) Stancer H S, et al:Treatment of intractable rapidcycling manic-depressive disorder with levothyroxine. Arch Gen Psychiatry 39311-312, 1982.
 
20) Leibow D:L-thyroxine for rapid cycling bipolar illness. Am J Psychiatry 140:1255, 1983.
PubMed
21) Bauer M S, et al:Rapid cycling bipolar affective disorder II. Treatment of refractory rapid cycling with high-dose levothyroxine. Apreliminary study. Arch Gen Psychiatry 46:435-440, 1990.
 
22) Wehr T A, et al:Rapid cycling affective disorders:contributing factors and treatmentresponses in 51 patients. Am J psychiatry 77:219-224, 1988.
 
P.212 掲載の参考文献
1) Akiskal H S, et al:The nosological status of neurotic depression. Arch Gen Psychiatry 35. 756-766, 1978
PubMed
2) American Psychiatric Association:Diagnostic and Statistical Manual of Mental Disorders; Forth Edition. American Psychiatric Association, Washington DC, 1994. (高橋 三郎, 他訳:DSM-IV精神疾患の分類と診断の手引. p 161-164. 医学書院. 東京. 1995.)
 
3) Kocsis J H, et al:Maintenance therapy for chronic depression. A controlled clinical trial of desipramine. Arch Gen Psychiatry 53. 769-774, 1996.
PubMed
4) Rosenthal T L, et al:Familial developmental factors in characterological depressions. J Affekt Disord 3. 183-192, 1981.
 
P.219 掲載の参考文献
1) American Psychiatric Association:Practice guideline for the treatment of patients with major depressive disorder (revision) . Am J Psychiatry 157 (4 suppl). 1-45, 2000.
 
2) Cullen M et al:Carbamazepile for treatrment-resistant melancholia J Clin Psychiatry 52:472-476, 1991.
 
3) Frank E, et al:Axis H personality disorders and personality features in treatment-resistant and refractory depression. In:Treat-ment Strategies for Refractory Depression. (Roose S P, et al, eds). p 207-221. American Psychiatric Press, Washington, DC, 1990.
 
4) 藤山直樹, 他:難治性うつ病の概念. 難治性うつ病 (上島国利, 編). p 5-16. ライフ・サイエンス, 東京, 1991.
 
5) Hayes S G:Long-term use of valproate in primary psychiatric disorders. J Clin Psychiatry 50:35-39, 1989.
PubMed
6) 井上 猛, 他:難治性うつ病の治療, 我が国における現状と治療アルゴリズム. 精神医学 39 (1):6-14, 1997.
 
7) 井上 猛, 他:難治性うつ病の薬物療法. 臨精医29 (8):1057-1062, 2000.
 
8) 上島国利:抗うつ薬の知識と使い方. p 93-100. ライフ・サイエンス, 東京, 1993.
 
9) Nelson J C, et al:Algorithms for the treatment of subtypes of unipolar major depression Am J Psychopharmacology Bulletin 31:475-482, 1995.
 
10) 本橋伸高: うつ病の治療. 医療ジャーナル 35:1341-1346, 1999.
 
11) Price L H, et al:Variability of response tolithium augmentation in refractory depression. Am J psychiatry 143:1387-1392, 1986.
 
12) Prudic J, et al:Refractory depression andelectro-convulsive therapy. In:Treatment Strategies for Refractory Depression. (Roose SP, et al eds), p 111-12 & American Psychiatric Press, Washington, DC, 1990.
 
13) Shioe K, et al:Algorithms of the pharma-cotherapy of major depression. Psychiatry and Clinical Neurosciences 53 (Suppl):S 77-S 82, 1999.
 
14) Thase M E, et al:Treatment-resistant depression. Psychopharmacology:The Fouth Generation Progress (Bloom F E, et al, eds). p 1081-1097. Raven Press, New York, 1995.
 
P.228 掲載の参考文献
1) Beck A T, et al:Hopelessness and eventual suicide:a 10-year prospective study of patients hospitalized with suicidal ideation. Am J Psychiatry 142 (3):559-563, 1985.
 
2) Conwell Y, et al:自殺の危険の高い高齢者の診断と治療について. 精神科診断学4 (2):161-171, 1993.
 
3) Kielholz P:Diagnose und Therapie der Depressionen fur den Praktiker, 3. Aufl. Munchen:Lehmanns, 1974.
 
4) 金田一勇, 他:うつ病・うつ状態と自殺. 精神科MOOK No. 16自殺 (春原千秋 編). p 130-140. 金原出版, 東京, 1987.
 
5) Poldinger W:Die Abschiftzung der Suizidal-itat. Bern:Huber, 1968.
 
6) Roose S P, et af Depression, delusion and suicide. Am J Psychiatry 140 (10):1159-1162, 1983.
 
7) 高橋邦明, 他:新潟県東頸城郡松之山町における老人自殺予防活動:老年期うつ病を中心に. 精神誌100 (7):469-485, 1998.
 
8) 高橋祥友:自殺の危険:臨床的評価と危機介入. 金剛出版, 東京, 1992.
 
9) 高橋祥友:群発自殺. 中央公論新社, 東京, 1998
 
10) 高橋祥友:医療者が知っておきたい自殺のリスクマネジメント. 医学書院, 東京, 2002.
 
P.236 掲載の参考文献
1) Akiskal H S, et al:Criteria for the "soft" bipolar spectrum:Treatment implications. Psychopharmacology Bulletin 23:68-73, 1987.
PubMed
2) Akiskal H S (広瀬徹也, 訳):soft Bipolarity-A foot note to Kraepelin 100 years later-. 臨精病理21:3-11, 2000.
 
3) 阿部隆明:双極スペクトラム (Bipolar spectrum) について. 最新精神医4 (1):21-29, 1999.
 
4) 加藤忠史:双極性II型障害. 臨床精神医学講座4. 気分障害 (広瀬徹也, 他 編) p 227-242. 中山書店, 東京, 1998.
 
5) 坂元 薫:気分循環症. 臨床精神医学講座4. 気分障害 (広瀬徹也, 他 編) p 273-289. 中山書店, 東京, 1998
 
6) 渋谷治男:大うつ病性障害. 臨床精神医学講座4. 気分障害 (広瀬徹也, 他 編) p 183-210. 中山書店, 東京, 1998
 
7) 上島国利:うつ病の薬物療法.臨床精神医学講座4. 気分障害 (広瀬徹也, 他 編) p 107-125. 中山書店, 東京, 1998
 
8) 高橋清久:季節性感情障害. 臨床精神医学講座4. 気分障害 (広瀬徹也, 他 編) p 305-323. 中山書店, 東京, 1998
 
9) 高橋三郎, 他 訳:DSM-IV-TR精神疾患の診断統計マニュアル6. 気分障害 p335-411. 医学書院, 東京, 2002.
 
10) 早馬俊, 他:気分変調症と重複うつ病. 臨精医29 (8):911-917, 2000.
 
11) 広瀬徹也:経過類型. 残遺状態と人格変化. 現代精神医学大系. 躁うつ病II 9 B, (高橋 良, 他 編). p 79-98中山書店, 東京, 1979.
 
12) 広瀬徹也:経過. 躁うつ病 (飯田 真 編) p 375-390. 国際医書出版, 東京, 1983.
 
13) 広瀬徹也:気分循環症. 精神科治療10 (臨):128-129, 1995.
 
14) 広瀬徹也:気分障害をめぐる諸問題. 臨精医29 (8):817-821, 2000.
 
15) 広瀬徹也:気分変調症について. ムードディスオーダー・カンファランス, p 87-107. 星和書店, 東京, 2001.
 
16) 野口俊文, 他:気分障害の疫学. 臨精医29 (8):823-827, 2000.
 
17) 松浪克文, 他:気分障害の精神病理-最新の知見-. 臨精医29 (8):843-852, 2000.
 
18) 山田和夫:ラピッドサイクラー. 臨床精神医学講座4. 気分障害 (広瀬徹也, 他 編) p 325-347. 中山書店, 東京, 1998.
 
P.245 掲載の参考文献
1) Greenberg P E et al:The economic burden of depression in 1990. J Clin Psychiatry 54:405-418, 1993.
PubMed
2) Kind P, et al:The cost of depression Int Clin Psychopharmacology 7:191-195, 1993.
 
3) Yamauchi K, et al:The economic burden of somatoform disorders. In:Somatoform Disorders:A Worldwide Perspective (Ono Y, et al eds). p 257-262 Springer-Verlag, Tokyo, 1999.
 
4) Greenberg P E, et al:Depression:A neglected major mness. J Clin Psychiatry 54:419-424, 1993.
 
5) Lepine J p, et al:Depression in the community:the first pan-European study DEPRES (Depression Research in European Society) . Int CHn Psychopharmacology 12:19-29, 1997.
 
6) Muto T, et al:Sickness absence due to mental diagnosis in Japanese workplace Industhal Health 37:243-252, 1999.
 
7) Berndt E R, et al:Workplace performance effects from chronic depression and its treatment J Health Economics 17:511-535, 1998
PubMed
8) Simon G E, et al:Recovery from depression. work productivity, and health care costs among pirmary care patients General Hospital Psychiatry 22:153-162, 2000.
 
9) Black N:Why we need observational studies to evaluate the effectiveness of health care. BMJ 312:1215-1218, 1996.
PubMed
10) Knapp M, et al:Economic aspects of depression and its treatment Curr Opin Psychiatry 15:69-75, 2002.
 
11) 山内慶太:わが国の臨床試験の方法論の再検討-特に多施設試験と有用性の意義について-. In:精神医学レビューNo. 25向精神薬の開発をめぐって(上島国利 編). p 92-192. ライフ・サイエンス社, 東京, 1997.
 
12) 湯尾高根, 他:医療経済学から見た新規抗うつ薬. 臨精薬理5:715-723, 2002.
 
13) Woods S W, et al Costreffectiveness of newer antidepressants. Curr Opin Psychiatry 10:95-101, 1997.
 
14) Rosenbaum J F, et al:Costs of depressive disorders:a review. In:Depressive disorder (Maj M, et al eds). p 401-449. John Wiley & Sons, Chichester, 1999.
 
15) Hotopf M, et al:Are SSRIs a cost-effective alternative to tricyclics?. Br J psychiatry 168:404-409, 1996.
PubMed
16) Barbui C, et al:Treatment discontinuation with selective serotonine reuptake inhibitors (SSRLs) versus nicyclic antidepressant (TCAs) (Cochrane Review). The Cochrane Library, Issue 1, 2002. Oxford:Update Software.
 
17) Donoghue J:Depression. In:Pharmacoeconomics in Psychiatry (Talor D, et al, eds). p 43-55. Martin Dunitz, London.
 
18) Simon G E, et al:Long-term outcomes of mitial antidepressant drug choice in a "real world" randomized trial. Arch Fam Med 8:319-325, 1999.
 
19) Churchill R, et al:A systematic review of controlled trials of the effectiveness and cost-effectiveness of brief psychological treatments for depression. Health Technol Assess 5 (35). 2001.
 
20) Scott AI, et al:Edinburgh primary care depression study:treatment outcome, patient satisfaction, and cost after 16 weeks. BMJ 304:883-887, 1992.
PubMed
21) Lave J R et al Cost-effectiveness of treatment for major depression in primary care practice. Arch Gen Psychiatry 55:645-651, 1998.
PubMed
22) Hirschfeld R M, et al:The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression. JAMA 277:333-340, 1997.
PubMed
23) Katon W, et ak Depression and somatization:a review part I Am J Medicine 72:127-135, 1982.
 
24) Regier D A, et al:The de facto US mental and addictive disorders service system:Epidemiologic Catchment Area prospective 1-year prevalence rates of disorders and ser vices. Arch Gen Psychiatry 50:85-94, 1993.
 
25) Katon W, et al:Adequacy and duration of antidepressant treatment in primary care. Med Care 30:67-76, 1992.
PubMed
26) Rupp A:The economic consequences of not treating depression. Br J psychiatry Suppl 27:29-33, 1995.
PubMed
27) Simpson S, et al A randomised controlled trial to evaluate the effectiveness and costeffectiveness of counselling patients with chron ic depression. Health Technol Assess 4 (36). 2000.
 
28) Simon G E, et al:Depression and work productivity:The comparative costs of treatment versus nontreatment J Occup Environ Med 43:2-9, 2001.
PubMed

第5章 躁うつ病のガイドライン

P.256 掲載の参考文献
1) Akiskal H S:The Clinical Management of Affective Disorder:Psychiatry. Vol 1. chapter 61 (Michels R et al eds). p 1-25. JB Lippincol Philadelphia, 1985. [F]
 
2) American Psychiatric Association (APA):Guideline for the treatment of patients with major depressive disorder (Revision) . Am J Psychiatry 157 (4) (Suppl):1-45, 2000
 
3) American Psychiatric Association (APA):Practice guideline for the treatment of patients with bipolar disorde(Revision) . Am J Psychiatry 159 (4) (Suppl):1-50, 2002.
 
4) Brown R A, et al:A Psychoeducational Approach to the Treatment of Depression:Comparison of Group, Individual and Minhnal Contact Procedures J Consult Clin Psychol 52:774-783, 1984.
 
5) 樋口輝彦:プライマリ・ケアにおける最近の抗うつ薬の使い方. Physicians:Therapy Manual 9 (4). 日本メディス社, 2002.
 
6) 塩江邦彦, 他:大うつ病のアルゴリズム (改訂版) の作成:主任研究者本橋伸高:厚生労働省精神・神経疾患研究委託費総括研究報告書「感情障害の薬物治療ガイドライン作成とその実証的研究」, p 33-41. 平成14年3月.
 
7) 山田和夫:Rapid cyclerに対する治療アルゴリズム:主任研究者本橋伸高:厚生労働省精神・神経疾患研究委託費総括研究報告書 「感情障害の薬物治療ガイドライン作成とその実証的研究」, p 47-50. 平成14年3月.
 

書評

最近チェックした商品履歴

Loading...